Vanadium and manic depressive psychosis.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 6443582)

Published in Nutr Health on January 01, 1984

Authors

G J Naylor

Articles citing this

Nutritional therapies for mental disorders. Nutr J (2008) 0.95

Nitric Oxide Synthase Inhibitors as Antidepressants. Pharmaceuticals (Basel) (2010) 0.75

Articles by these authors

Rates of mitochondrial DNA evolution in sharks are slow compared with mammals. Nature (1992) 2.82

Structural biology and phylogenetic estimation. Nature (1997) 1.34

A double-blind comparison of paroxetine and placebo in the treatment of depressed patients in a psychiatric outpatient clinic. Acta Psychiatr Scand Suppl (1989) 1.17

Lithium in non-manic-depressives: antiaggressive effect and red blood cell lithium values. Br J Psychiatry (1975) 1.08

Defective genetic control of sodium-pump density in manic depressive psychosis. Psychol Med (1981) 1.08

A two-year double-blind crossover trial of the prophylactic effect of methylene blue in manic-depressive psychosis. Biol Psychiatry (1986) 1.08

Erythrocyte membrane cation carrier in depressive illness. Psychol Med (1973) 1.03

Hydrophobicity and phylogeny. Nature (1995) 1.02

Sleep patterns in depressive states. Br J Med Psychol (1972) 1.01

Rapid flux in plant genomes. Nat Genet (1998) 0.99

A controlled trial of methylene blue in severe depressive illness. Biol Psychiatry (1987) 0.97

Vitamin D intoxication, with hypernatraemia, potassium and water depletion, and mental depression. Br Med J (1968) 0.90

Controlled studies of the acute antidepressant effects of lithium. Br J Psychiatry (1979) 0.90

Short-cycle manic depressive psychosis in mental defectives: a clinical and physiological study. J Ment Defic Res (1976) 0.90

Erythrocyte membrane cation carrier in mania. Psychol Med (1976) 0.88

A biochemical study of short-cycle manic-depressive psychosis in mental defectives. Br J Psychiatry (1976) 0.88

A double-blind trial of long-term lithium therapy in mental defectives. Br J Psychiatry (1974) 0.88

Tissue vanadium levels in manic-depressive psychosis. Psychol Med (1984) 0.87

Erythrocyte membrane cation carrier, relapse rate of manic-depressive illness and response to lithium. Psychol Med (1976) 0.87

Plasma vanadium concentration in manic-depressive illness. Psychol Med (1982) 0.86

Lithium and erythrocyte membrane cation carrier studies in normal and manic depressive subjects. Psychol Med (1977) 0.86

Emotional disturbance following childbirth: clinical findings and urinary excretion of cyclic AMP (adenosine 3'5'cyclic monophosphate). Psychol Med (1979) 0.85

Elevated vanadium content of hair and mania. Biol Psychiatry (1984) 0.84

Plasma magnesium and calcium levels in depressive psychosis. Br J Psychiatry (1972) 0.84

Trial of digoxin in mania. Lancet (1975) 0.82

Plasma tryptophan concentration in depressive illness and mania. Br J Psychiatry (1976) 0.82

Methylene blue in mania. Biol Psychiatry (1988) 0.82

The effect of digoxin on the response to lithium therapy in mania. Psychol Med (1982) 0.81

Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry (1986) 0.81

Lithium therapy and erythrocyte membrane cation carrier. Psychopharmacologia (1974) 0.80

Erythrocyte membrane cation carrier in manic-depressive psychosis. Psychol Med (1980) 0.80

Methylene blue. A possible treatment for manic depressive psychosis. J Affect Disord (1983) 0.80

Changes in erythrocyte sodium and potassium on recovery from a depressive illness. Br J Psychiatry (1971) 0.79

Catecholamine metabolism in affective disorders: excretion of 3-methoxy-4-hydroxymandelic acid in depressive states. Can Psychiatr Assoc J (1972) 0.79

Plasma concentrations of protriptyline and clinical effects in depressed women. Br J Psychiatry (1976) 0.79

Possible explanation for therapeutic action of lithium, and a possible substitute (methylene-blue) Lancet (1981) 0.79

Phylogenetic inference from conserved sites alignments. J Exp Zool (1999) 0.78

Lithium side effects in a routine lithium clinic. Br J Psychiatry (1979) 0.78

A double blind placebo controlled trial of ascorbic acid in obesity. Nutr Health (1985) 0.77

Reversal of vanadate-induced inhibition of Na-K ATPase. A possible explanation of the therapeutic effect of carbamazepine in affective illness. J Affect Disord (1985) 0.77

Vanadium: a possible aetiological factor in manic depressive illness. Psychol Med (1981) 0.77

Changes in the erythrocyte sodium pump with age. Gerontology (1977) 0.77

Prediction of clinical course of bipolar manic depressive illness treated with lithium. Psychol Med (1980) 0.77

Cation transport in lymphoblastoid cell lines established from bipolar manic-depressive patients. J Affect Disord (1989) 0.76

Unpleasant taste--a neglected symptom in depression. J Affect Disord (1989) 0.76

A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients. Psychol Med (1981) 0.76

Factor VIII-related antigen and procoagulant activity in manic-depressive patients. J Affect Disord (1983) 0.76

Pharmacokinetic aspects of protriptyline plasma levels. Eur J Clin Pharmacol (1977) 0.76

Erythrocyte sodium and potassium in depre- ssive illness. J Psychosom Res (1970) 0.76

The therapeutic effect of ascorbic acid and EDTA in manic-depressive psychosis: double-blind comparisons with standard treatments. Psychol Med (1984) 0.76

Some biochemical findings during pregnancy and after delivery in relation to mood change. Psychol Med (1982) 0.75

The effect of mianserin on urinary catecholamine excretion in psychiatric patients. Br J Clin Pharmacol (1981) 0.75

Profound hypothermia on combined lithium carbonate and diazepam treatment. Br Med J (1977) 0.75

Tyramine conjugation and antidepressants. Lancet (1989) 0.75

Bromocriptine in mania--a placebo-controlled double-blind trial. Br Med J (1980) 0.75

The relationship between age and sodium metabolism in human erythrocytes. Gerontologia (1970) 0.75

Methylene blue excretion in depression. Biol Psychiatry (1989) 0.75

A model for phylogenetic inference using structural and chemical covariates. Pac Symp Biocomput (2001) 0.75

The plasma control of erythrocyte sodium and potassium metabolism in depressive illness. J Psychosom Res (1970) 0.75

Catalysis of the reduction of vanadate by psychotropic drugs. Neuropharmacology (1983) 0.75

Cyclic AMP levels in blood cells from a short-cycle manic-depressive subject. Br J Psychiatry (1980) 0.75

Urinary excretion of adenosine 3' :5'-cyclic monophosphate in depressive illness. Br J Psychiatry (1974) 0.75

Reduced ouabain binding to erythrocytes in epilepsy--evidence for a membrane abnormality. Epilepsy Res (1989) 0.75

Depot injections for affective disorders. Br J Psychiatry (1980) 0.75

New approaches to the treatment of manic depressive illness. Neuropharmacology (1980) 0.75

Conflicting phylogenetic patterns caused by molecular mechanisms in mitochondrial DNA sequences. Syst Biol (1998) 0.75

Caesium levels in manic depressive psychosis. J Affect Disord (1989) 0.75

Methysergide in mania: a double-blind comparison with thioridazine. Psychol Med (1972) 0.75

Indoleamine metabolism in affective disorders: excretion of tryptamine, indoleacetic acid and 5-hydroxy-indoleacetic acid in depressive states. J Psychosom Res (1972) 0.75

The antidepressant properties of mianserin and its effect on sleep. Acta Psychiatr Belg (1979) 0.75

Trace elements in manic depressive psychosis. J Affect Disord (1985) 0.75

A study of plasma tryptophan and tyrosine in mania. Postgrad Med J (1977) 0.75

Clomipramine and flupenthixol--additive antidepressants? Br J Psychiatry (1987) 0.75

Whole blood adenosine triphosphate in manic-depressive illness. Br J Psychiatry (1976) 0.75

A double-blind out-patient trial of indalpine vs mianserin. Br J Psychiatry (1985) 0.75

Incorporation of inositol into the phosphoinositides of lymphoblastoid cell lines established from bipolar manic-depressive patients. J Affect Disord (1990) 0.75

Letter: Lithium in manic-depressive illness. Lancet (1974) 0.75

Vanadium and affective disorders. Biol Psychiatry (1983) 0.75

Erythrocyte ouabain binding in dementia. Gerontology (1983) 0.75

Sodium and potassium transport in depressive illness. J Physiol (1972) 0.75

Changes in erythrocyte membrane cation carrier with age in women. Gerontology (1980) 0.75

A controlled trial of L-tryptophan in mania. Br J Psychiatry (1978) 0.75

A simple method for the determination of protriptyline in plasma. Clin Chim Acta (1973) 0.75